Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation. [electronic resource]
Producer: 19951129Description: 601-9 p. digitalISSN:- 0026-895X
- Adenosine Triphosphate -- metabolism
- Angiotensin II -- pharmacology
- Angiotensin Receptor Antagonists
- Animals
- Autoradiography
- Base Sequence
- Biphenyl Compounds -- pharmacology
- Calcium -- metabolism
- Cyclic AMP -- metabolism
- Cytoplasm -- metabolism
- Dactinomycin -- pharmacology
- Down-Regulation -- drug effects
- Enzyme Activation -- drug effects
- Imidazoles -- pharmacology
- Losartan
- Molecular Sequence Data
- Muscle Proteins -- metabolism
- Muscle, Smooth, Vascular -- metabolism
- Protein Kinase C -- antagonists & inhibitors
- Protein Processing, Post-Translational -- drug effects
- Protein Synthesis Inhibitors -- pharmacology
- Purinergic P1 Receptor Agonists
- Purinergic P2 Receptor Agonists
- RNA, Messenger -- genetics
- Rats
- Rats, Sprague-Dawley
- Receptors, Angiotensin -- genetics
- Receptors, Purinergic P1 -- physiology
- Receptors, Purinergic P2 -- physiology
- Signal Transduction -- drug effects
- Tetrazoles -- pharmacology
- Transcription, Genetic -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.